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Abstract
Regulatory T (Treg) cells, expressing abundant amounts of the IL-2 receptor (IL-2R), are reliant on 
IL-2 produced by activated T cells. This feature implied a key role for a simple network based on 
IL-2 consumption by Treg cells in their suppressor function. However, congenital deficiency in 
IL-2R results in reduced expression of the Treg cell lineage specification factor Foxp3, 
confounding experimental efforts to understand the role of IL-2R expression and signaling in Treg 
suppressor function. Using genetic gain and loss of function approaches, we demonstrate that IL-2 
capture is dispensable for control of CD4+ T cells, but is important for limiting CD8+ T cell 
activation, and that IL-2R dependent STAT5 transcription factor activation plays an essential role 
in Treg cell suppressor function separable from T cell receptor signaling.
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Regulatory T (Treg) cells expressing the transcription factor Foxp3 restrain immune 
responses to self and foreign antigens1-3. Treg cells express abundant amounts of the 
interleukin 2 receptor  ?-chain (IL-2R ?; CD25), but are unable to produce IL-2. IL-2 binds 
with low affinity to IL-2R ? or the common  ? -chain ( ?c)-IL-2R ? heterodimers, but 
receptor affinity increases ~1,000 fold when these three subunits together interact with 
IL-24. IL-2 and STAT5, a key IL-2R downstream target, are indispensable for Foxp3 
induction and differentiation of Treg cells in the thymus5-11. IL-2R ? and  ?c are shared with 
the IL-15 receptor, whose signaling can also contribute to the induction of Foxp312. IL-2, in 
cooperation with the cytokine TGF- ?, is also required for extrathymic Treg cell 
differentiation13.
While the role for IL-2R signaling in the induction of Foxp3 expression and Treg cell 
differentiation in the thymus has been well established by previous studies, the significance 
of IL-2R expression in mature Treg cells is not well understood. Although the deficiency in 
STAT5 abolishes Foxp3 expression, it can be rescued by increased amounts of the anti-
apoptotic molecule Bcl2. This finding raised a possibility that a primary role for IL-2 is in 
the survival of differentiating Treg cells or their precursors14. It was also reported that 
ablation of the proapoptotic protein Bim can rescue Treg cells or their precursors from 
apoptosis associated with IL-2 or IL-2R deficiency and restore Treg cell numbers, but it did 
not prevent fatal autoimmunity15. However, a profound effect of a congenital deficiency in 
IL-2, Bcl2 and Bim on differentiation and selection of Treg and self-reactive effector T (Teff) 
cells confounds interpretation of this observation. Antibody-mediated neutralization of IL-2 
in thymectomized mice reduces Treg cell numbers and Foxp3 expression in Treg cells16, 17. 
Thus, IL-2 supports Treg cell lineage stability after differentiation18, 19. However, expression 
of a transgene encoding IL-2R ? chain exclusively in thymocytes was reported to rescue the 
lethal autoimmune disease in Il2rb−/− mice, suggesting that IL-2R expression is dispensable 
in peripheral Treg cells7, 11. Thus, a role for IL-2R expression and signaling in peripheral 
Treg cells remains uncertain. Hypothetically, a role for IL-2R in peripheral Treg cells could 
be threefold: 1) guidance for Treg cells to sense their targets – activated self-reactive T cells, 
which serve as a source of IL-2; 2) Treg cell-mediated deprivation of IL-2 as a mechanism of 
suppression, and 3) cell-intrinsic IL-2 signaling in differentiated Treg cells to support their 
maintenance, proliferation, or function due to triggering of JAK–STAT5, PI3K–Akt, or Ras–
ERK signaling pathways. Previous studies primarily focused on the induction or 
maintenance of Foxp3, while other aspects of IL-2R function have not been firmly 
established due to aforementioned limitations.
Despite their high reliance on IL-2 for the maintenance of Foxp3 expression, Treg cells are 
unable to produce IL-2. The reason for the inhibition of autologous activation of STAT5 in 
Treg cells, and potential biological significance of this IL-2-based Treg-Teff cell regulatory 
loop, also remain unknown. It has been suggested that repression of IL-2 is required to 
maintain the ‘ unbound’  state of high affinity IL-2R on Treg cells, and unbound IL-2R serves 
a key role in Treg cell-mediated suppression by depriving Teff cells of IL-220-24, however, 
whether this mechanism has a non-redundant role in suppression in vivo is unknown.
To address the role of IL-2R and downstream signaling pathways in differentiated Treg cells, 
we ablated IL-2R ?, IL-2R ?, and STAT5 in Foxp3-expressing cells. By simultaneously 
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inducing expression of an active form of STAT5, we assessed the differential requirements 
for IL-2R expression and IL-2 signaling for Treg cell homeostasis vs. suppressor activity.
Results
IL-2R is indispensable for Treg cell function
To definitively establish a role for IL-2R in Treg cell function in vivo, we generated a Treg 
cell-specific IL-2R ? conditional knockout mice using Cre recombinase driven by the 
endogenous Foxp3 locus (Foxp3Cre), in which a loxP-flanked Il2rb allele (Il2rbfl/fl) was 
deleted in Treg cells after Foxp3 was expressed. Il2rbfl/flFoxp3Cre mice developed systemic 
fatal autoimmune inflammatory lesions and lymphoproliferation, albeit somewhat milder 
than that observed in Foxp3− mice (Fig. 1a–c). IL-2R ? expression was diminished in 
peripheral IL-2R ?-deficient Treg cells (Fig. 1d), and tyrosine phosphorylation of STAT5 in 
response to IL-2 was lacking (Fig. 1e). The frequency of Foxp3+ cells among CD4+ T cells 
and the expression of Foxp3 on a per-cell basis were both diminished (Fig. 1f). In healthy 
heterozygous Il2rbfl/flFoxp3Cre/wt females, where both IL-2R ?-sufficient (YFP−) and -
deficient (YFP+) Treg cells co-exist due to random X-chromosome inactivation, IL-2R ?-
deficient Treg cells were underrepresented (Fig. 1g, h). It has been suggested that IL-2 is 
selectively required for the maintenance of CD62LhiCD44lo Treg cells, but is dispensable for 
CD62LloCD44hi Treg cells25. However, we found both CD62LhiCD44lo and CD62LloCD44hi 
Treg cells to be significantly reduced in the absence of IL-2R ? in healthy heterozygous 
females. In these mice, IL-2R ?-deficient Treg cells expressed reduced amounts of Foxp3 and 
Treg-cell ‘ signature’  molecules IL-2R ? chain (CD25), CTLA-4, GITR, and CD103 
regardless of CD62L and CD44 expression (Fig. 1i, j and Supplementary Fig. 1a). 
Although in diseased Il2rbfl/flFoxp3Cre mice, a majority of Treg cells were CD62LloCD44hi, 
this was likely a consequence of severe inflammation, because Treg cell frequencies were 
also markedly reduced at sites where CD62LloCD44hi cells were prevalent, i.e., the small 
and large intestines (Supplementary Fig. 1b). Accordingly, many characteristic Treg cell 
markers, except for CD25 and Foxp3, were upregulated as the result of Treg cell activation in 
Il2rbfl/flFoxp3Cre mice (Supplementary Fig. 1c). These observations suggested that both 
CD62LhiCD44lo and CD62LloCD44hi Treg cell subsets, including those residing in the non-
lymphoid tissues, are dependent on IL-2, though under inflammatory conditions the latter 
can be sustained to some extent by IL-2R-independent signals. Despite the upregulation of 
CTLA-4, GITR, ICOS, and CD103, the ‘ activated’  IL-2R ?-deficient Treg cells from 
Il2rbfl/flFoxp3Cre mice were still incapable of controlling inflammation in the diseased mice 
and were not suppressive when co-transferred with Teff cells into lymphopenic recipients 
(data not shown).
Our findings raised the question whether ablation of IL-2R ?, which, in addition to 
facilitating IL-2 signaling, enables its sequestration from Teff cells, would result in a similar 
Treg cell deficiency and disease compared to those in Il2rbfl/flFoxp3Cre mice. Thus, we 
generated a loxP-flanked Il2ra allele (J.D.F. manuscript in preparation) and similarly 
induced its conditional ablation in Treg cells. We found that Treg cell-specific IL-2R 挀 
deficiency resulted in a disease with comparable early onset and severity to those observed 
upon IL-2R ? ablation (Supplementary Fig. 1d–f). Of note, germ-line deficiency of either 
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Il2ra or Il2rb in mice on the same C57BL6/J as our conditional knockout mice resulted in a 
considerably less aggressive disease with a delayed onset, likely due to a role for IL-2R 
signaling in Teff cells (data not shown). Our findings also indicate that IL-15 was unable to 
effectively compensate for the loss of IL-2 signaling in differentiated Treg cells because in 
Foxp3CreIl2rafl/fl mice, Treg cells lacked only IL-2 signaling, whereas in Il2rbfl/flFoxp3Cre 
mice, they lacked both IL-2 and IL-15 signaling yet were similarly affected. This was in 
contrast to Treg cell differentiation in the thymus where IL-15 can contribute in part to Foxp3 
induction12. Since IL-2R activates PI3K–Akt, MAPK, and JAK–STAT5 signaling pathways, 
we next sought to assess a role for STAT5 activation downstream of IL-2R signaling in Treg 
cells. We found that STAT5 ablation similarly impaired Treg cell function and 
Foxp3CreStat5a/bfl/fl mice were similarly affected by fatal autoimmunity as were mice 
harboring IL-2R deficient Treg cells (Supplementary Fig. 1g–k). Thus, in agreement with 
IL-2 neutralization studies, IL-2R signaling is required for Treg cell fitness in a cell-intrinsic 
manner.
STAT5b-CA partially rescues IL-2R deficient Treg function
The above findings implied that STAT5 activation downstream of IL-2R is continuously 
required for Treg cell function. However, a marked decrease in IL-2R observed in STAT5-
deficient Treg cells (Supplementary Fig. 1g) made it impossible to separate a loss of STAT5 
from impairment in all IL-2R functions, i.e., detection of IL-2, transduction of STAT5-
dependent and -independent signals, and consumption and deprivation of IL-2, as a key 
contributor to the observed severe Treg cell dysfunction.
To address this major caveat and to understand a role for STAT5 vs. IL-2R, we asked 
whether expression of a gain-of-function form of STAT5b can rescue Treg cell function in 
the absence of IL-2R. A previous study using a transgene encoding a constitutively active 
form of STAT5b (STAT5b-CA) driven by the proximal lck promoter in the absence of 
IL-2R ? showed rescue of Treg cell differentiation in the thymus, but not lymphoproliferative 
syndrome9. However, the expression of this transgene early during thymopoiesis leads to 
leukemic lymphoproliferation, which complicated the interpretation of these findings. In 
addition, both the activity of the proximal lck promoter and the expression of the transgene 
diminish in peripheral T cells in these mice9. Therefore, we generated a gene-targeted mouse 
strain utilizing the Rosa26 ‘ gene trap’  locus26, where a ‘ CAG’  promoter driven STAT5b-
CA27 is preceded by a loxP-flanked STOP cassette (Supplementary Fig. 2a). In the 
resulting Rosa26Stat5bCA mice, STAT5b-CA is expressed only when the loxP sites undergo 
Cre mediated recombination. Introduction of the Rosa26Stat5bCA allele into Il2rbfl/flFoxp3Cre 
mice and the consequent expression of STAT5b-CA in IL-2R ?-deficient Treg cells rescued 
the systemic inflammation and early fatal disease (Supplementary Fig. 2b). In these mice, 
Treg cell frequencies and numbers were comparable to or even surpassed their levels in 
IL-2R sufficient Foxp3Cre mice (Fig. 2a). Notably, the expression of IL-2R ? chain was 
increased despite the absence of IL-2R ? chain (Fig. 2a), suggesting the expression of 
IL-2R ? on Treg cells is primarily controlled by STAT5-dependent, but not by STAT5-
independent signaling. Importantly, these IL-2R ?-deficient Treg cells with heightened 
IL-2R ? expression remained unresponsive to IL-2 (Fig. 2b).
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The observed restoration of the suppressor function of IL-2R ?-deficient Treg cells and rescue 
of the early fatal disease upon STAT5b-CA expression raised the possibility that the 
reintroduced high IL-2R ? levels were responsible for these effects. However, the expression 
of STAT5b-CA similarly rescued the early fatal disease in Foxp3CreIl2rafl/fl mice 
(Supplementary Fig. 2c–h). Importantly, although the impaired capacity of Treg cells in 
both Il2rbfl/flFoxp3Cre and Foxp3CreIl2rafl/fl mice to capture and consume IL-2 was not 
rescued upon STAT5b-CA expression (Fig. 2c), CD4+ T cell reactivity was fully controlled 
in these mice (Fig. 2d and Supplementary Fig. 2d–h). These results suggested that the 
ability to capture and compete for IL-2 is dispensable for Treg cell mediated suppression of 
CD4+ T cell responses. To the contrary, however, expansion of CD8+ T cells, in particular, 
of activated CD62LhiCD44hi CD8+ T cells, was only marginally restrained in these mice 
(Fig. 2d and Supplementary Fig. 2f, h). Although the expansion of CD8+CD62LloCD44hi 
subset was relatively well, albeit not perfectly, controlled in neonatal mice (Fig. 2d and 
Supplementary Fig. 2f), this subset also gradually started to expand in these mice as early 
as 3 wks after birth (Supplementary Fig. 2i). Although both 
Il2rbfl/flFoxp3CreRosa26Stat5bCA and Il2rafl/flFoxp3CreRosa26Stat5bCA mice were rescued 
from premature death and showed significantly improved clinical status comparable to 
healthy controls, they gradually failed to thrive and started to succumb to disease 
accompanied by massively expanded activated CD62LhiCD44hi and CD62LloCD44hi CD8+ 
T cell subsets in LNs and tissues by approximately 12 wks of age (Supplementary Fig. 2i, 
j). These findings raised a possibility that IL-2 consumption by Treg cells, while dispensable 
for control of CD4+ T cells, is important for the restraint of CD8+ T cells.
Treg cells suppress CD8+ T cell responses via IL-2 depletion
To test if the impairment in consumption of IL-2 by Treg cells can account for the 
proliferation of CD8+ T cells in Foxp3CreIl2rbfl/flRosa26Stat5bCA mice, we administered IL-2 
neutralizing antibodies to these and control mice starting from 5–7 days of age (Fig. 2e and 
Supplementary Fig. 3a). As IL-2 supports the differentiation of Treg cells in the thymus, 
IL-2 neutralization reduced the frequencies of Treg cells in all groups of mice and induced 
immunoactivation in control Il2rbfl/wtFoxp3Cre mice. In Il2rbfl/flFoxp3Cre mice, which 
spontaneously develop disease, the production of TH2 cytokines IL-4 and IL-13 by CD4+ T 
cells was significantly reduced by IL-2 neutralization; however, the activation of CD4+ and 
CD8+ T cells was at best only marginally reduced or unaffected. In contrast, the activation 
and proliferation of CD8+ T cells observed in Il2rbfl/flFoxp3CreRosa26Stat5bCA mice were 
almost completely suppressed by the treatment.
The relative reduction in CD8+CD62LloCD44hi and more pronounced proliferation of 
CD8+CD62LhiCD44hi T cell subset in Il2rbfl/flFoxp3CreRosa26Stat5bCA and 
Il2rafl/flFoxp3CreRosa26Stat5bCA mice raised a possibility that a loss of IL-2-consumption by 
Treg cells might selectively impair their suppression for memory CD8+ T cell expansion, but 
not the recruitment of naive CD8+ T cells into the effector cell pool. We tested this idea by 
adoptive transfer of CD4+ and CD8+ cell subsets into lymphopenic recipients (Fig. 2f). 
Consistent with the observation in Foxp3Cre mice, the impaired suppression of CD4+ T cell 
expansion and activation by IL-2R-deficient Treg cells was completely rescued by STAT5b-
CA; in contrast, their ability to suppress memory CD8+ T cells was not restored, whereas 
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suppression of naive CD8+ T cell expansion and expansion was only partially recovered. 
Thus, IL-2 consumption by Treg cells appears to have a non-redundant role in suppressing 
the expansion and activation of both naive and memory CD8+ T cell subsets, although this 
mechanism appears to be particularly prominent in control of the latter subset.
Although the majority of activated CD8+ T cells in Il2rbfl/flFoxp3Cre and 
Il2rbfl/flFoxp3CreRosa26Stat5bCA mice did not express detectable levels of IL-2R 挀 
(Supplementary Fig. 3a), these cells could activate STAT5 in response to IL-2, albeit to a 
lesser extent than that observed in cells expressing IL-2R 挀 (Supplementary Fig. 3b). A 
small proportion of activated CD4+ T cells with undetectable IL-2R ? expression also 
responded to IL-2, but the majority of them did not. CD8+ T naive cells also responded to 
IL-2, while CD4+ T naive cells did not. Thus, both naive and activated CD8+ T cells 
appeared to be more sensitive to IL-2 than CD4+ T cells, and IL-2 consumption by Treg cells 
may markedly affect their activation. A corollary to this notion was that STAT5 activation in 
CD8+, but not CD4+ T cells may render the former resistant to Treg cell mediated 
suppression. Thus, we tested the effect of STAT5 activation on the proliferation of CD4+ and 
CD8+ T cells in the presence of Treg cells. For this purpose, we sorted CD4+Foxp3− and 
CD8+Foxp3− T cells from Foxp3CreRosa26Stat5bCA mice and induced the expression of 
STAT5b-CA in these cells by treating them with a recombinant Cre protein containing a 
membrane permeable TAT (trans-activating transcriptional activator from HIV virus) peptide 
(TAT-Cre). We adoptively transferred the treated cells into lymphopenic recipients with or 
without Treg cells. Although TAT-Cre treatment initially induced STAT5b-CA expression in 
approximately 30% of the treated CD4+ and CD8+ T cells, more than 95% of CD8+ T cells 
expressed STAT5b-CA three weeks after the transfer; whereas STAT5b-CA expressing 
CD4+ T cells expanded to 40-50% (Fig. 2g). Notably, STAT5b-CA+CD8+ T cells robustly 
expanded in the presence of either control (Foxp3Cre) or STAT5b-CA+ Treg cells (Fig. 2g, 
h). Although some degree of suppression of STAT5b-CA+CD8+ T cells by Treg cells was 
still observed, it was very mild compared to the suppression of STAT5b-CA−CD8+ T cells 
(Fig. 2h). In contrast, proliferation of and cytokine production by activated CD4+ T cells, 
regardless of the expression of STAT5b-CA, were well controlled by Treg cells (Fig. 2h). 
These observations suggest that STAT5 activation in CD8+, but not in CD4+ T cells prompts 
robust expansion of cells and confers pronounced resistance to Treg cell mediated 
suppression. Consistent with these findings, gain-of-function experiments where IL-2 was 
provided in the form of IL-2/ IL-2 immune complexes showed expansion of CD8+ T and 
CD4+ Treg, but not of CD4+ T cells28. Thus, while the ability to capture and compete for 
IL-2 is dispensable for Treg cell mediated suppression of CD4+ T cell responses, this mode 
of suppression appears essential for control of CD8+ T cells, which respond to excessive 
IL-2 more robustly than CD4+ T cells.
STAT5 activation in Tregcells boosts immunosuppression
The lack of detectable STAT5 activation in response to IL-2 and of STAT5b-CA-driven 
expansion of IL-2R-sufficient Treg cells that escaped from Cre-mediated recombination 
(counterselection) in both Il2rbfl/flFoxp3CreRosa26Stat5bCA and 
Il2rafl/flFoxp3CreRosa26Stat5bCA mice indicated that the expression of an active form of 
STAT5 relieved Treg cells from their dependence on IL-2 signaling. This finding offered a 
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unique opportunity to explore the biological significance of the aforementioned IL-2-
dependent Treg–Teff cell regulatory network by uncoupling Treg cell function from IL-2 
production by Teff cells. To address this question, we generated 
Rosa26Stat5bCAFoxp3Cre-ERT2 mice, which enabled tamoxifen-inducible expression of 
STAT5b-CA in differentiated Treg cells17. Induction of STAT5b-CA expression in ~20–30% 
of Treg cells upon a single tamoxifen administration was followed by their rapid increase in 
numbers at the expense of Treg cells with a non-recombined Rosa26Stat5bCA allele 
(Supplementary Fig. 4a, b). It is noteworthy that these cells exhibited a highly diverse TCR 
V ? usage similar to that in control mice (Supplementary Fig. 4c).The experimental 
Foxp3Cre-ERT2Rosa26Stat5bCA mice remained healthy (Supplementary Fig. 4d, e). In these 
mice, the proliferated STAT5b-CA+ Treg cell population exhibited increased amounts of 
Foxp3, CD25, CTLA4, and GITR and an increased proportion of CD62LhiCD44hi vs. 
CD62LhiCD44lo cells, indicative of a STAT5b-CA impressed biasing of the Treg cell 
population towards an activated or memory cell state (Fig. 3a–d and Supplementary Fig. 
4f). Consistent with the latter possibility, surface expression of IL-7R, KLRG1, and CD103 
were increased (Fig. 3d). Notably, in lymph nodes (LNs) and Peyer's patches (PPs), Treg 
cells were not numerically increased despite the predominance of STAT5b-CA+ Treg cells 
(Supplementary Fig. 4b, g), suggesting that Treg cells with activated STAT5 preferentially 
distribute in non-lymphoid tissues. CD8+Foxp3+ cells were also increased upon induction of 
STAT5b-CA (Supplementary Fig. 4h). The ‘ autonomous’  Treg cells, expressing active 
STAT5 showed heightened in vitro suppressor activity (Supplementary Fig. 4i) and 
effectively suppressed the basal state of activation and proliferative activity of CD4+ and 
CD8+ T cells in vivo, as well, as evidenced by the decreased numbers of Ki-67+ cells and 
CD62LloCD44hi Teff cells and a markedly increased CD62LhiCD44lo T naive cell pool (Fig. 
3e and Supplementary Fig. 5a, b). Accordingly, CD4+ T cell production of pro-
inflammatory cytokines, most prominently IL-4, and expression of CD80 and CD86 by B 
cells and dendritic cells (DCs) were reduced (Supplementary Fig. 5c and Fig. 3f). These 
results indicate that expression of STAT5-CA confers increased suppressor function to Treg 
cells. Previously, Treg cells were proposed to promote systemic TH17 type responses and 
IgA class switching in the gut29, 30. However, we found that serum and fecal IgA as well as 
TH17 responses in secondary lymphoid organs were reduced, rather than increased in the 
presence of STAT5b-CA+ Treg cells (Fig. 3g and Supplementary Fig. 5c). Serum IgM and 
IgE also showed a tendency towards a decrease, but this was not statistically significant 
(Supplementary Fig. 5d). These results were in agreement with an increase in TH17 
responses and in both TH2- and TH1-type Ig class switch observed upon acute Treg cell 
ablation31. Since altered intestinal immune responses have been implicated in promoting 
colonic carcinogenesis, we explored an effect of a gain in Treg cell suppressor function 
afforded by activated STAT5 in an ApcMin model of colorectal cancer. Mice harboring the 
ApcMin mutation develop multiple adenomatous polyps in the small intestine32. 
ApcMinFoxp3Cre-ERT2Rosa26Stat5bCA mice developed a comparable or fewer numbers of 
polyps, but the average polyp size was increased (Supplementary Fig. 5e). These results 
were consistent with the idea that suppression of inflammation by Treg cells in tumor 
microenvironments promotes the growth of tumors once tumors or pre-cancerous lesions are 
already formed. However, the early stages of colonic carcinogenesis appeared not to be 
promoted but were potentially suppressed by Treg cells with augmented suppressor activity.
Chinen et al. Page 7
Nat Immunol. Author manuscript; available in PMC 2017 March 05.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
In addition to restraining the basal immune reactivity in physiological settings and 
modulating colon carcinoma development, ‘ autonomous’  Treg cells afforded superior 
protection against autoantigen-induced autoimmunity. We found that 
Foxp3Cre-ERT2Rosa26Stat5bCA mice were highly resistant to experimental autoimmune 
encephalomyelitis (EAE) (Fig. 4a–c). The frequencies of CD4+Foxp3+ cells were 
significantly increased in the brain and spinal cord of these mice (Fig. 4b), and infiltration of 
inflammatory cells, including neutrophils and IL-17-producing CD4+ TH17 cells into these 
organs, was significantly reduced (Fig. 4c). Pathogen-specific responses were also 
diminished in Foxp3Cre-ERT2Rosa26Stat5bCA mice. Although Listeria-specific TH1 responses 
were only modestly suppressed (Fig. 4d), vaccinia virus-specific CD8+ T cell responses 
were markedly reduced in the presence of STAT5b-CA+ Treg cells (Fig. 4e). Our observation 
of diminished responses to infectious agents and modulation of cancer progression may 
provide a rationale as to why Treg cells lack IL-2 production and autonomous activation of 
STAT5, and instead are reliant on activated T cells as a source of IL-2.
A distinct role for STAT5 activation in Treg cells
Next, we sought to address the question of how sustained STAT5 signaling may potentiate 
Treg cells’  suppressive ability. In genetic loss- and gain-of-function studies, STAT5 activity 
in Treg cells correlated with their proliferative capacity and expression of IL-2R ? and 
Foxp3. However, the in vitro suppression assays above, as well as the reduction in immune 
activation in LNs and PPs of Foxp3Cre-ERT2Rosa26Stat5bCA mice, where fewer Treg cells 
were found than in control mice suggested that the enhanced immunosuppression observed 
in Foxp3Cre-ERT2Rosa26Stat5bCA mice was not simply due to a numerical increase of Treg 
cells, but that their suppressor activity on a per cell basis was also augmented. It was also 
unlikely that mild upregulation of Foxp3 in the presence of STAT5b-CA could account for 
the increased suppressor activity of Treg cells as we found that genome-wide Foxp3 binding 
does not change upon activation of Treg cells, which lead to an increase in Foxp3 expression 
more pronounced than the one caused by STAT5b-CA33. The increase in Foxp3 protein in 
STAT5b-CA+ Treg cells compared to control was particularly noticeable in the CD25lo Treg 
cell subset (Fig. 3b; Average fold changes in Foxp3 MFI in Foxp3+ Treg cells from 
Foxp3Cre-ERT2Rosa26Stat5bCA mice vs. those from Foxp3Cre-ERT2 mice; CD25hi = 1.06 fold, 
CD25lo = 1.36 fold (n = 6)), consistent with the observation that STAT5b-CA+ Treg cells 
were relieved from their dependence on IL-2. Nevertheless, STAT5b-CA+ Treg cells 
exhibited a more potent suppressor function than CD25hiFoxp3hi Treg cells from control 
mice when co-transferred with Teff cells into lymphopenic recipients despite comparably 
high expression of Foxp3 (data not shown). Thus, the increased suppressor activity of 
STAT5b-CA+ Treg cells was unlikely to be due to the increased Foxp3.
To gain insight into the potential mechanisms underlying the heightened suppressor function 
conferred by sustained STAT5 activation, we sorted mature Treg cells from Foxp3Cre-ERT2 
and Foxp3Cre-ERT2Rosa26Stat5bCA mice that expressed comparable levels of Foxp3 and 
analyzed gene expression in these cells using RNA-seq. While the gene expression profiles 
of CD4+ T naive cells from both groups of mice were nearly identical, Treg cell gene 
expression was markedly affected by the active form of STAT5 (Fig. 5a and Supplementary 
Fig. 6a). Among all expressed genes (~11,000) in either Treg or CD4+ T naive cell 
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populations analyzed, 342 genes were upregulated and 314 genes were downregulated in 
STAT5b-CA+ Treg cells compared to control cells (Fig. 5b and Supplementary Fig. 6b). 
The gene set upregulated in STAT5b-CA+ Treg cells encoded various cell surface molecules 
and receptors involved in cell adhesion, migration, and cytoskeletal reorganization (Fig. 5c). 
Several genes that were upregulated or downregulated in control Treg cells compared to T 
naive cells showed opposite trends in STAT5b-CA+ Treg cells, suggesting that STAT5b-CA 
does not simply reinforce the Treg cell signature. A previous study showed that exposure of 
Treg cells to inflammation induced upon transient Treg cell depletion leads to a marked 
change in their gene expression and a potent increase in their suppressor function33. 
Consistent with the heightened suppressor function of STAT5b-CA+ Treg cells, we found 
that the gene expression changes in these cells conferred by an active form of STAT5 
correlated with those found in highly activated Treg cells in inflammatory settings (Fig. 5d). 
TCR signaling is required for the ability of Treg cells to exert their suppressor function34, 35. 
Thus, it was possible that TCR and STAT5 dependent signaling pathways in Treg cells are 
acting upon a largely overlapping set of genes whose expression they jointly regulate to 
potentiate Treg cell suppressor activity. However, our analysis revealed that the gene set 
affected by the active form of STAT5 was distinct from that expressed in Treg cells in a TCR-
dependent manner (Fig. 5d). Thus, both TCR and STAT5 signaling pathways play an 
indispensable role in Treg cell suppressor activity in vivo by controlling largely distinct sets 
of genes and likely distinct aspects of Treg cell suppressor activity.
To better understand aspects of Treg cell function potentiated by STAT5 activation, we 
performed signaling pathway and molecular function enrichment analyses, which revealed 
overrepresentation of gene sets involved in cell-cell and extracellular matrix interactions, 
cell adhesion, and cellular locomotion among genes differentially expressed in STAT5b-CA+ 
Treg cells (Fig. 5e, f, Supplementary Fig. 6c). This result suggested that in Treg cells, 
STAT5 activation might potentiate their interactions with the target cells. Since intravital 
imaging of Treg cells in vivo had previously revealed their stable interactions with DCs36, we 
assessed the potential effect of constitutively active STAT5 expression in Treg cells on their 
ability to form conjugates with DCs in vitro. In agreement with the gene set enrichment 
analysis, we found that STAT5b-CA expression in Treg cells promotes conjugate formation 
between Treg and DCs (Fig. 6a). Heightened interactions of STAT5b-CA+ Treg cells with 
DCs in vitro were consistent with the decreased expression of co-stimulatory molecules by 
DCs observed in tamoxifen-treated Foxp3Cre-ERT2Rosa26Stat5bCA mice.
These findings raised a question whether STAT5 activation can potentiate the suppressor 
function of Treg cells in a TCR-independent manner. To test this notion, we analyzed 
Foxp3Cre-ERT2Rosa26Stat5bCA mice expressing a conditional Tcra allele. As we reported 
previously, tamoxifen-inducible Cre-mediated TCR ablation in Treg cells is highly efficient 
in these mice and resulted in immune activation resulting from impaired suppressor 
function34. In heterozygous Foxp3Cre-ERT2Tcrafl/wt mice, Cre mediated recombination can 
theoretically result in ablation of TCR in up to a half of Treg cells due to the allelic exclusion 
at the Tcra locus. We observed a small proportion of TCR-deficient Treg cells after 2-wks of 
tamoxifen administration in these mice (Fig. 6b). Although the expression of the active form 
of STAT5 was observed in ~50% of TCR-sufficient and -deficient Treg cells in 
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Foxp3Cre-ERT2Tcrafl/wtRosa26Stat5bCA mice, the proportion of only TCR-sufficient, but not -
deficient STAT5b-CA expressing Treg cells was increased. The marked increase in T cell 
activation and pro-inflammatory cytokine production was mitigated in part upon expression 
of the active form of STAT5 in tamoxifen-treated Foxp3Cre-ERT2Tcrafl/flRosa26Stat5bCA mice 
(Fig. 6c). This partial recovery of Treg cell suppressor function by the active form of STAT5 
in TCR-ablated Treg cells was also confirmed in experiments where flow-sorted TCR-
deficient STAT5b-CA+ Treg cells and Teff cells were adoptively transferred into lymphopenic 
recipients (Fig. 6d). Although the rescue was incomplete, these results suggested that 
enhanced STAT5 signaling could potentiate Treg cell suppressor activity in the absence of 
contemporaneous TCR-dependent signals. Indeed, some features of Treg cells that had been 
observed in TCR-sufficient STAT5b-CA+ Treg cells were still present in TCR-ablated 
STAT5b-CA+ Treg cells (Fig. 6c, d). It should be noted, however, that STAT5b-CA 
expression failed to rescue suppressor function in Foxp3CreTcrafl/flRosa26Stat5bCA mice 
where TCR deletion occurred immediately after the induction of Foxp3. It was previously 
shown that TCR signaling is required for Treg cells to acquire an activated, antigen-
experienced phenotype and suppressor function34. Thus, our results suggest that activation 
of STAT5 potentiates TCR-independent suppressor function in mature Treg cells that have 
already undergone TCR-dependent maturation. This observation is reminiscent of the 
sequential requirement for these two signals, TCR and IL-2R, in the differentiation of Treg 
cells in the thymus where STAT5 signal promotes differentiation of Treg precursors that have 
experienced permissive TCR signaling37.
Discussion
Previous analysis of mice with germ-line deficiency in IL-2 and IL-2R subunits 
demonstrated that IL-2 is a key cytokine required for the induction of Foxp3 and the 
differentiation of Treg cells in the thymus5-11 . Furthermore, antibody-mediated IL-2 
neutralization and provision of IL-2-complexes, as well as genetic dissection of regulatory 
elements within the Foxp3 locus, revealed an important role for IL-2 in the maintenance of 
mature Treg cells and in stabilization of Foxp3 expression during their extrathymic 
differentiation16, 28, 38. These findings raised a question of whether IL-2R signaling can also 
directly promote Treg cell suppressor capacity and, therefore, serve as a critical nexus linking 
differentiation and maintenance of Treg cells with their suppressor function. An early in vitro 
study proposed a role for IL-2 signaling based on indirect evidence21. In addition, IL-2 
consumption by Treg cells was suggested to play an essential role in Treg cell suppressor 
function by causing death of activated CD4+ T cells due to IL-2 deprivation20-24. On the 
other hand, other reports suggested that IL-2R is dispensable for the ability of Treg cells to 
suppress effector T cell proliferation8, 39. Furthermore, the rescue of the disease in Il2ra−/− 
and Il2rb−/− mice observed upon adoptive transfer of wild-type Treg cells suggested the 
existence of major mechanisms of Treg cell-mediated suppression independent of IL-2-
deprivation6, 7. However, the latter studies left open a major question as to whether IL-2 
consumption by Treg cells is essential for suppression of IL-2R-sufficient Teff cells since 
IL-2 is likely a major driver of autoimmune disease in the absence of functional Treg cells.
A major limiting factor in efforts to experimentally assess a role for IL-2R signaling in, and 
IL-2 consumption by Treg cells in their function in vivo has been the lack of adequate 
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genetic tools. We addressed this issue through generation of conditional Il2ra and Il2rb 
alleles and their ablation in Treg cells in combination with the induced expression of an 
active form of STAT5. These new genetic tools enabled us to unequivocally demonstrate that 
IL-2R signaling has a cell intrinsic, non-redundant role not only in the maintenance of 
mature Treg cells and their fitness, but also in their suppressor function. Furthermore, we 
found that STAT5 deficiency in Treg cells results in a similar loss of suppressor function and 
that expression of an active form of STAT5 can rescue fatal disease resulting from IL-2R 
deficiency. These results suggest a key role of IL-2R–STAT5 signaling in linking 
differentiation and maintenance of Treg cells and their function. STAT5 binds to the Foxp3 
promoter and the intronic Foxp3 regulatory element CNS2 and is involved in Foxp3 
induction and maintenance38. Runx-CBF ? complexes also bind to CNS2 and the Foxp3 
promoter and affect Foxp3 expression levels40. Although both CNS2- and CBF ?-deficient 
Treg cells do exhibit reduced Foxp3 expression resembling that of STAT5- or IL-2R-deficient 
Treg cells, the impairment of suppressor function in the latter was much more severe. Thus, 
the decrease in Foxp3 expression alone cannot account for a severe loss of Treg cell 
suppressor function in the absence of STAT5 or IL-2R. Indeed, our analysis of gene 
expression and functional features conferred upon expression of the active form of STAT5 
pointed to a heightened ability of Treg cells to bind to DC and suppress their activation. 
Furthermore, expression of an active form of STAT5 partially rescued the near-complete loss 
of Treg suppressor function in the absence of TCR signaling34, 35. These results may appear 
at odds with the previous finding that STAT5b-CA transgene driven by the proximal lck 
promoter and Eμenhancer failed to curtail fatal lymphoproliferative disease in Il2rb−/− mice 
despite restoring Foxp3 expression and Treg cell differentiation in the thymus9. However, the 
interpretation of the latter result is problematic due to a massive expansion of pre-leukemic 
T and B cells and reduced expression of the STAT5b-CA transgene in peripheral Treg cells.
Our studies clearly demonstrated that IL-2-deprivation by Treg cells was fully dispensable 
for suppression of IL-2R-sufficient CD4+ T cells even though IL-2R signaling was required. 
However, IL-2R dependent IL-2 consumption by Treg cells was indispensable for 
suppression of CD8+ T cell responses. The latter seemingly unexpected finding makes sense 
in light of the observed exquisite sensitivity of both naive and activated CD8+ T cells to IL-2 
induced stimulation. Furthermore, IL-2 is produced upon activation of both naive CD4+ and 
CD8+ T cells within hours after TCR engagement in contrast to effector cytokines such as 
IL-4 and IFN- ? whose production requires T naive cell differentiation into Teff cells on a 
much longer time scale41. These distinguishing features provide a likely explanation for a 
need for a distinct mechanism of control of CD8+ T cell responses by Treg cells through IL-2 
consumption.
It has been suggested that sensing of local IL-2 production by Treg cells enables ‘ licensing’  
of their suppressor function21. However, the rescue of suppression of CD4+ T cell responses 
by IL-2R-deficient Treg cells expressing an active form of STAT5 suggests that activated Treg 
cells can suppress autoimmunity without identifying the cellular source of IL-2. Thus, while 
IL-2 is a booster for Treg cell suppressor function, it may not play an indispensable role as a 
cue for specific targeting.
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Genetically modified T cells are emerging as a potent means of therapy in some forms of 
cancer. The observed enhanced suppressor activity of Treg cells expressing an active form of 
STAT5 and significantly reduced severity of organ-specific autoimmunity in their presence 
suggest that such a modification of Treg cells may hold promise for an optimal design of Treg 
cell-based therapies for a variety of autoimmune and inflammatory disorders and in organ 
transplantation.
Our findings highlight the central role of IL-2 receptor signaling driven STAT5 activation in 
supporting and boosting suppressor function of differentiated Treg cells. In this regard, it is 
noteworthy that although a Foxp3 ortholog has not been identified in birds, chicken and 
duck CD4+ T cell subsets expressing high amounts of IL-2R ? chain possess in vitro 
suppressor activity suggesting the importance of evolutionary conservation of IL-2R 挀 
function in suppressive T cells42, 43.
Methods
Mice
Foxp3Cre and Foxp3Cre-ERT2 mice were described previously17, 44. Il2rafl mice were 
generated by J.D.F. Stat5a/bfl mice were provided by L Henninghausen. ApcMin mice were 
purchased from the Jackson Laboratory. The targeting strategies to generate Il2rbfl 
(generated by U.K.) and Rosa26Stat5bCA alleles are shown in Supplementary Fig. 7. Tcrafl 
mice were described previously34. The experimental mice were either generated on or 
backcrossed onto a C57BL/6J (B6) background, bred and housed in the specific pathogen-
free animal facility at Memorial Sloan Kettering Cancer Center (MSKCC). All animal 
experiments were approved by institutional animal care and use committee at MSKCC and 
were performed in accordance with the institutional guidelines. For survival analysis, mice 
were monitored daily and unhealthy mice were euthanized once they are found lethargic and 
counted as non-survivors. For tamoxifen treatment, tamoxifen (Sigma-Aldrich) was 
dissolved in olive oil at a concentration of 40 mg/ml. Mice were given oral gavage of 100 μl 
of tamoxifen emulsion per treatment. In EAE and infection experiments, mice were 
challenged 2 to 3 months after a single tamoxifen gavage and assessed as described 
previously38.
Flow cytometry and cell sorting
Cells were stained with fluorescently tagged antibodies purchased from eBioscience, BD 
Biosciences, Tonbo Bioscience, or BioLegend (Supplementary Table 2) and analyzed using 
a BD LSR II flow cytometer. Flow cytometry data were analyzed using FlowJo software 
(TreeStar). For intracellular cytokine staining, cells were stimulated for 5 hr with CD3 and 
CD28 antibodies (5 μg/ml each) in the presence of brefeldin A or monensin, harvested and 
stained with eBioscience Fixation Permeabilization kit. For intracellular phosphorylated 
STAT5 staining, cells were stimulated with or without rmIL-2 for 20 min, fixed and 
permeabilized with 4% PFA followed by 90% methanol, and stained with anti-pY-STAT5 
antibody (BD Biosciences). Cell sorting of Foxp3+ and Foxp3− cells was performed based 
on YFP or GFP expression using a BD FACSAria II cell sorter.
Chinen et al. Page 12
Nat Immunol. Author manuscript; available in PMC 2017 March 05.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Listeria and Vaccinia infection
Mice were intravenously injected into the tail vein with Listeria monocytogenes 
(LM10403S; 2000 cells/mouse) on day 0 and analyzed on day 8. For the detection of 
Listeria-specific immune responses, splenic DCs from unchallenged B6 mice sorted using 
CD11c microbeads (Miltenyi) were cultured in wells of a 96 well U-bottom plate (2 × 104 
cells/well) with heat-killed Listeria monocytogenes (2 × 107 cells/well) for 6 hr prior to the 
analysis. The cells were then co-cultured with splenic T cells obtained from Listeria-infected 
mice (1 × 105 cells/well) for 5 hr in the presence of brefeldin A, and cytokine producing T 
cells were detected by flow cytometry. For vaccinia virus infection, mice were 
intraperitoneally injected with non-replicating virus (5 × 107 PFU/mouse) on day 0 and 
analyzed on day 8. Splenocytes were re-stimulated with several vaccinia virus derived 
antigenic peptides (1 μg/ml) for 5 hr in the presence of brefeldin A, and cytokine producing 
T cells were detected by flow cytometry.
In vivo IL-2 neutralization
Mice were i.p. injected with a cocktail of two different anti-IL-2 monoclonal antibodies 
JES6-1 and S4B6-1 (BioXcell) or isotype matched control antibody (rat IgG2a, 2A3; 
BioXcell), 200 μg each, twice a week, starting from 5–7 days after birth.
TAT-Cre protein treatment of T cells
For the induction of STAT5b-CA expression in non-Treg cells, 1 × 107 CD4+Foxp3− or 
CD8+Foxp3− T cells sorted from the LNs and spleens of Foxp3Cre and 
Foxp3CreRosa26Stat5bCA mice were resuspended in 2 ml of serum-free RPMI media 
containing a TAT-Cre recombinase (Millipore; 50 μg/ml) and incubated at 37°C for 45 min. 
The cells were washed with RPMI containing 10% FCS, resuspended in PBS, and injected 
into T cell-deficient (Tcrb−/−Tcrd−/−) mice together with or without separately sorted Treg 
cells for in vivo suppression assay.
In vitro IL-2 capture assay
Pooled cells from LNs and spleens were depleted of B cells and accessary cells by panning 
and T cells were enriched. The cells were stained with anti-CD8 and anti-B220 Abs, and 
CD4+ Treg cells were sorted on the basis of GFP (YFP) expression alone in CD8-negative 
population. The sorted cells were divided among 8 wells of a 96-well V-bottomed plate (2 × 
105 cells/well) in 25 μl RPMI medium (10% FCS) with or without increasing doses of 
recombinant human IL-2 (0.016 to 12 U/ml), followed by incubation for 2 h at 37 °C. 
Depletion of IL-2 from the medium was assessed with the BD Cytometric Bead Array and 
Human IL-2 Enhanced Sensitivity Flex Set according to the manufacturer's instructions (BD 
Biosciences).
In vitro T–DC conjugation assay
Treg cells and non-Treg cells were sorted in the same manner as IL-2 capture assay. Splenic 
CD11c+ DCs were isolated by MACS from B6 mice injected with Flt3L-secreting B16 
melanoma cells. Treg and non-Treg cells were stained with CFSE. DCs were stained with 
CellTrace Violet (Molecular Probes). 1 × 104 Treg or non-Treg cells were cultured together 
Chinen et al. Page 13
Nat Immunol. Author manuscript; available in PMC 2017 March 05.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
with graded numbers of DCs (1 × 104 to 1 × 105) in a 96-well round-bottomed plate for 720 
min in the presence or absence of rmIL-2 (100 IU/ml). Frequencies of Treg cells conjugated 
with DCs (% CTV+CFSE+/CFSE+) were analyzed by flow cytometry.
In vitro suppression assay
Naive CD4+ T cells (responder cells) and Treg cells were FACS purified and stained with 
CellTrace Violet (CTV). 4 × 104 naive CD4+ T cells were cultured with graded numbers of 
Treg cells in the presence of 1 × 105 irradiated, T-cell-depleted, CFSE-stained splenocytes 
and 1 μg/ml anti-CD3 antibody in a 96 round-bottom plate for 80 hr. Cell proliferation of 
responder T cells and Treg cells (live CFSE−CD4+Foxp3− and Foxp3+) was determined by 
flow cytometry based on the dilution of fluorescence intensity of CTV of the gated cells.
Measurements of serum and fecal immunoglobulin levels
Serum IgM, IgG1, IgG2a, IgG2b, IgG2c, IgG3 and IgA levels were determined by ELISA 
using SBA Clonotyping System (Southern Biotech). IgE ELISA was performed using 
biotinylated anti-IgE antibody (BD Biosciences) and HRP-conjugated streptavidin. For 
measurement of fecal IgA levels, fresh fecal pellets were collected and dissolved in 
extraction buffer (7 μl per mg pellet) containing 50 mM Tris-HCl, 150 mM NaCl, 0.5% 
NP-40, 1mM EDTA, 1 mM DTT, and protease inhibitor cocktail (Complete mini; Roche). 
Supernatants were collected after centrifugation, titrated, and IgA levels were measured by 
ELISA.
Statistical Analysis for Animal Experiments
Each mouse was tagged with a unique identification number, and researchers were blinded 
to the genotypes of mice except for adjusting sample size included in a single experiment 
and after data analysis is completed. Wild type mice with suspected congenital anomalies 
were excluded from the study. Cell samples that showed less than 70% cell vitality after 
preparation or after in vitro stimulation were excluded from the study. Statistical analyses 
were performed using Prism software with two-tailed unpaired Student's t test. Welch's 
correction was applied when F test was positive. P values < 0.05 were considered 
significant.
RNA sequencing
Male 8-wk-old Foxp3Cre-ERT2Rosa26Stat5bCA (STAT5b-CA) and Foxp3Cre-ERT2 (control) 
mice, nine mice for each experimental group, received a single dose (4 mg) of tamoxifen by 
oral gavage 4 months before isolation. Splenic CD4+Foxp3(YFP/GFP)+GITRhiCD25hi Treg 
and CD4+Foxp3(YFP/GFP)−CD62LhiCD44lo naive T cells were double sorted using a BD 
FACSAria II cell sorter, and a total of 12 samples were generated. Spleen T cell subsets 
isolated from three individual mice in the same experimental group were pooled into one 
biological replicate; three biological replicates were subjected to RNA-seq analysis for each 
experimental group. Total RNA was extracted and used for poly(A) selection and Illumina 
TruSeq paired-end library preparation following manufacturer's protocols. Samples were 
sequenced on the Illumina HiSeq 2500 to an average depth of 27.5 million 50-bp read pairs 
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per sample. All samples were processed at a same time and sequenced on the same lane to 
avoid batch effects.
Read alignment and processing followed the method previously described45. Briefly, raw 
reads were trimmed using Trimmomatic v0.32 with standard settings to remove low-quality 
reads and adaptor contamination46. The trimmed reads were then aligned to the mouse 
genome (Ensembl assembly GRCm38) using TopHat2 v2.0.11 implementing Bowtie2 v2.2.2 
with default settings. Read alignments were sorted with SAMtools v0.1.19 before being 
counted to genomic features using HTSeq v0.6.1p1. The overall read alignment rate across 
all samples was 74.5%. Differential gene expression was analyzed using DESeq2 1.6.3 in R 
version 3.1.047.
Bioinformatic analyses for RNA-seq
The distribution of read counts across all genes was bimodal. The assumption that this 
corresponded to “expressed” and “non-expressed” genes was supported by examination of 
marker genes known to be expressed or not expressed in Treg and T naive cells. The local 
minimum between the two peaks was chosen to be the threshold for expression. Using this 
threshold of ~60 normalized reads, 10,589 out of 39,179 genes were called as present. 
Significantly up- (342 genes) and down-regulated (314) genes between STAT5b-CA versus 
control Treg cells were defined as expressed genes with fold changes of at least 1.5× or 
0.67×, respectively, and FDR-adjusted P-value ≤ 0.05.
TCR-upregulated (i.e., TCR-dependent) genes were defined as genes downregulated (at least 
0.57× fold change) in TCR-deficient compared to TCR-sufficient CD44hi Treg cells, while 
TCR-downregulated genes are upregulated (at least 1.75×, Padj ≤ 0.001) in TCR-deficient 
CD44hi Treg cells (GSE61077)34. Activation-upregulated genes are genes upregulated (2× 
fold change, Padj ≤ 0.01) in Treg cells from Foxp3DTR mice recovering from punctual Treg 
cell depletion (GSE55753)33.
Signaling Pathway Impact Analysis (SPIA) was performed using the R package of the same 
name48. Significantly up- and downregulated genes, and their fold changes, were analyzed 
as one set for enrichment and perturbation of 90 Mus musculus KEGG pathways accessed 
on October 5, 2015. The net pathway perturbation Z-score was calculated using the observed 
net perturbation accumulation, and the mean and SD of the null distribution of net 
perturbation accumulations. Global P-values were calculated using the normal inversion 
method with Bonferroni correction.
Biological process (BP) gene ontology (GO) term over-representation was calculated using 
BiNGO v3.0.349 in Cytoscape v3.2.1, employing the hypergeometric test and applying a 
significance cutoff of FDR-adjusted P-value ≤ 0.05. The 10,589 expressed genes were 
entered as the reference set, and the GO ontology and annotation files used were 
downloaded on Oct. 25, 2015 (Supplementary Table 1). The output from BiNGO was 
imported into EnrichmentMap v2.0.150 in Cytoscape to cluster redundant GO terms and 
visualize the results. An EnrichmentMap was generated using a Jaccard similarity 
coefficient cutoff of 0.2, a P-value cutoff of 0.001, an FDR-adjusted cutoff of 0.005, and 
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excluding gene sets with fewer than 10 genes. The network was visualized using a prefuse 
force-directed layout with default settings and 500 iterations. Groups of similar GO terms 
were manually circled.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
IL-2R ? is indispensable for Treg cell function. (a) Histopathology of indicated organs of 
Foxp3CreIl2rbfl/wt and Foxp3CreIl2rbfl/fl mice. Scale bar, 100 μm. (b) Lymph node (LN) 
cellularity of indicated mice. (c) Cytokine production by splenic CD4+Foxp3− cells 
stimulated for 5 hr with anti-CD3/CD28. (d) IL-2R subunit expression by CD4+Foxp3+ cells 
from Foxp3CreIl2rbfl/wt (blue) and Foxp3CreIl2rbfl/fl (red) mice. (e) Intracellular phospho-
STAT5 levels in Treg cells from the indicated mice unstimulated (US) or in vitro stimulated 
with rmIL-2 (1,000 U/ml) for 20 min. (f) The frequencies of Treg cells among LN 
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CD3+CD4+ cells (left) and Foxp3 expression levels (MFI: mean fluorescence intensity) in 
the CD3+CD4+ Foxp3+ cells (right). (g-j) The analysis of healthy heterozygous female 
Foxp3Cre/wt mice. (g) YFP (Cre) expression and intracellular Foxp3 staining identify Treg 
cells with or without YFP-Cre expression. Gates shown are for CD3+CD4+ cells. (h) The 
frequencies of Foxp3+ cells among CD3+CD4+ cells (upper panel) and of Cre expressing 
cells among Foxp3+ cells (lower panel) in the indicated organs of Foxp3Cre/wtIl2rbfl/wt 
(black) and Foxp3Cre/wtIl2rbfl/fl (red) mice. (i) Foxp3 expression levels (MFI) in 
YFP−Foxp3+ (upper panel) and YFP+Foxp3+ (lower panel) cells. (j) The expression of 
indicated markers in YFP+Foxp3+ cells. Cells were analyzed by flow cytometry (b–j). 3–5 
wk-old sex and age matched mice were analyzed. *, P < 0.05; **, P < 0.01; ***, P < 0.001; 
NS, not significant (two-tailed unpaired Student's t test). Data are from one experiment 
representative of three independent experiments with similar results with three or more mice 
per group in each (b, c, f, h, i, j; each dot represents a single mouse; mean ± s.e.m.) or 
representative data of more than five (a) or ten (d, e, g) mice per group analyzed are shown.
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Figure 2. 
Restoration of the suppressor activity of IL-2R-deficient Treg cells in the presence of an 
active form of STAT5. (a) The frequencies of Foxp3+ cells among CD3+CD4+ cells and 
CD122 and CD25 expression by CD3+CD4+Foxp3+ cells. (b) Intracellular phospho-STAT5 
levels in LN Treg cells from the indicated mice unstimulated (US) or in vitro stimulated with 
rmIL-2 (1,000 U/ml) for 20 min. (c) In vitro IL-2 capture assay. Treg and non-Treg cells from 
the indicated mice were sorted and cultured for 2 hr with recombinant human IL-2 (hIL-2). 
The amount of residual hIL-2 in the media after 2 hr was measured using flow cytometry-
based bead array analysis and shown as percent value. (d) The cell numbers of indicated 
CD4+ and CD8+ cell subset (both CD3+Foxp3−) in the LNs of indicated mice (2 wk old). (e) 
The frequencies of naive (CD62LhiCD44lo) T cells among CD3+CD4+Foxp3− and 
CD3+CD8+Foxp3− cells (upper two panels) and the numbers of CD44hi activated 
CD3+CD4+Foxp3− and CD3+CD8+Foxp3− cells (lower two panels) in the LNs of indicated 
mice treated with IL-2 neutralizing antibodies or control IgG for 2 wks starting from day 5–
7 after birth. (f) Analysis of the ability of IL-2R-sufficient and -deficient Treg cells to 
suppress the expansion of naive and activated/memory CD4+ and CD8+ T cells. 
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CD4+Foxp3−CD62LhiCD44lo (CD4+ naive), CD8+Foxp3−CD62LhiCD44lo (CD8+ naive), 
and CD8+Foxp3−CD62LhiCD44hi (CD8+ memory) T cells were sorted from Foxp3Cre mice 
and adoptively transferred (1 × 106 cells each) into T cell-deficient (Tcrb−/−Tcrd−/−) mice 
together with Treg cells (2 × 105 cells) sorted from the indicated mice. CD4+Foxp3− and 
CD8+Foxp3− T cell numbers in the LNs of recipients 3 wks after transfer are shown. (g, h) 
Analysis of susceptibility of CD4+ and CD8+ T cells expressing an active form of STAT5 to 
Treg mediated suppression. (g) The frequencies of STAT5b-CA-expressing CD4+ and CD8+ 
Teff cells within total CD4+ and CD8+ Teff cells 3 wks after a transfer of in vitro TAT-Cre 
recombinase treated CD4+Foxp3− and CD8+Foxp3− T cells sorted from 
Foxp3CreRosa26Stat5bCA mice and transferred (1 × 106 cells each) into Tcrb−/−Tcrd−/− 
recipients. (h) The numbers and proportion (%) of IFN- ?-producing CD4+ and CD8+ T cells 
in the recipients without a co-transfer of Treg cells (red bars) or with 2 × 105 control (black 
bars) or STAT5b-CA-expressing Treg cells (blue bars) sorted from Foxp3Cre or 
Foxp3CreRosa26Stat5bCA mice, respectively. As a control, CD4+Foxp3− and CD8+Foxp3− T 
cells sorted from Foxp3CreRosa26wt mice were similarly treated with TAT-Cre and 
transferred to assess the susceptibility of STAT5b-CA− Teff cells to Treg mediated 
suppression (open bars). *, P < 0.05; **, P < 0.01; ***, P < 0.001; NS, not significant (two-
tailed unpaired Student's t test). Data are from one experiment representative of two (b, c, e, 
f) or three (a, d, g, h) independent experiments with similar results with two or more (a, b) 
or three or more (c, d, e, f, g, h) mice per group in each experiment (each dot represents a 
single mouse; mean ± s.e.m.).
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Figure 3. 
Increased proliferative and suppressor activity of Treg cells expressing an active form of 
STAT5. (a–g) Analysis of Foxp3Cre-ERT2 (black dots) and Foxp3Cre-ERT2Rosa26Stat5bCA 
(blue dots) mice three months after a single tamoxifen treatment. (a) The frequencies of 
Foxp3+ cells among CD3+CD4+ cells (upper graph) and the expression levels of Foxp3 in 
CD3+CD4+Foxp3+ cells (lower graph) in the indicated organs. Sp: spleen, SILPL: small 
intestine lamina propria lymphocytes. (b) Analysis of splenic CD4+ T cells for the 
expression of CD25 and Foxp3. (c) Analysis of splenic CD4+Foxp3+ Treg cells. (d) The 
expression of indicated markers in splenic CD4+Foxp3+ Treg cells. (e) Analysis of splenic 
CD3+CD4+Foxp3− (upper panels) and CD3+CD8+Foxp3− (lower panels) cells. (f) The 
expression of CD80 and CD86 on DCs (CD11c+MHC class IIhi) and B cells 
(B220+CD11c−) in the LNs. (g) Serum and fecal IgA levels as determined by ELISA. Sex 
and age matched mice were analyzed. Cells were analyzed by flow cytometry (a–f). *, P < 
0.05; **, P < 0.01; ***, P < 0.001 (two-tailed unpaired Student's t test). Data are from one 
experiment representative of two (a, d, f, g) independent experiments with similar results 
with five or more mice per group in each experiment (a, d, f, g; each dot represents a single 
mouse; mean ± s.e.m.) or representative data of more than ten mice per group analyzed are 
shown (b, c, e).
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Figure 4. 
Potent suppressor function of Treg cells expressing an active form of STAT5. (a–c) Analysis 
of EAE induced upon immunization with MOG peptide in CFA. (a) Average disease scores 
(n=10 each). (b) The frequencies Foxp3+ cells among brain-infiltrating CD3+CD4+ (left) 
and CD3+CD8+ (right) cells in mice shown in (a). (c) The numbers of the indicated brain-
infiltrating cells in mice shown in (a). (d) T cell responses against Listeria monocytogenes in 
uninfected (UI) or infected (Inf; day 8 after infection) mice. The frequencies of Foxp3+ Treg 
cells among CD3+CD4+ cells (left). The frequencies of IFN- ?(middle) and TNF 挀 (right) 
producing CD4+TCR ?+Foxp3− cells after 5 hr in vitro re-stimulation with heat-killed 
Listeria in the presence of DCs. (e) Anti-viral T cell responses in mice on day 8 after 
infection with non-replicating vaccinia virus. The frequencies of vaccinia B8R peptide-
specific CD8+ T cells detected using H-2Kb-B8R tetramer (left), IFN- ? production by 
CD8+Foxp3− (middle) and CD4+Foxp3− (right) cells after a 5 hr in vitro stimulation with 
B8R peptide or a mixture of three vaccinia virus-specific peptides (ISK, A33R, and B5R). 
Cells were analyzed by flow cytometry (b–e). Sex and age matched Foxp3Cre-ERT2 (black) 
and Foxp3Cre-ERT2Rosa26Stat5bCA (blue) mice were challenged or infected as indicated 2-3 
months after a single tamoxifen treatment. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (two-
tailed unpaired Student's t test). Data are from one experiment representative of two 
independent experiments with similar results with ten (a–c) or four (e) mice per group in 
each experiment, or pooled from four independent experiments with n=11 (UI), n=15 (Inf, 
control), or n=20 (Inf, Rosa26Stat5bCA) mice per group are shown (d). Each dot represents a 
single mouse (b–e). mean ± s.e.m. (a–e).
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Figure 5. 
RNA-seq analysis of Treg cells expressing an active form of STAT5. (a) Principal component 
analysis of RNA-seq datasets, using the top 15% of genes with the highest variance. Each 
dot represents an RNA sample from a single mouse. Note that “Stat5bCA T naive” cells are 
T naive cells sorted from tamoxifen-treated Foxp3Cre-ERT2Rosa26Stat5bCA mice and do not 
express STAT5b-CA. Only “Stat5bCA Treg” cells express STAT5b-CA in the four groups of 
cells presented. (b) Plot of gene expression (as log2 normalized read count) in control vs. 
STAT5b-CA expressing Treg cells. The diagonal lines indicate fold change of at least 1.5× or 
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0.67× fold. Significantly up- and down-regulated genes (defined as genes with at least 1.5× 
or 0.67× fold change, adjusted P-value ≤ 0.05, and expression above a minimal threshold 
based on the distribution of all genes) are colored red or blue, respectively, and their 
numbers are shown. (c) Heat map of selected genes. Three replicates are shown in order. P-
values are for control Treg vs. STAT5b-CA expressing Treg cells. (d) The empirical 
cumulative distribution function (ECDF) for the log2 fold change of all expressed genes in 
STAT5b-CA vs. control Treg cells, is plotted along with ECDFs for the subsets of genes up- 
or down-regulated by inflammatory activation in Treg cells33 (upper graph), or the subsets of 
genes up- or down-regulated in a TCR-dependent manner in CD44hi Treg cells34 (lower 
graph). (e) Signaling Pathway Impact Analysis (SPIA) of KEGG pathways. The 6 most 
statistically significant pathways that show enrichment among differentially expressed (DE) 
genes in STAT5b-CA vs. control Treg cells are shown. The net pathway perturbation 
indicates the status of the pathway (positive = activated; negative = inhibited) based on the 
activating or inhibitory relationships of DE genes within the pathway. The size of the red 
circle is proportional to the degree of enrichment, and the FDR-adjusted global P-value 
reflecting both enrichment and perturbation is shown. (f) Network analysis of GO term 
enrichment among significantly upregulated genes in STAT5b-CA vs. control Treg cells. 
Upregulated genes were analyzed for over-represented GO terms using BiNGO in 
Cytoscape, and the resulting network was calculated and visualized using EnrichmentMap. 
Groups of similar GO terms (Supplementary Table 1) were manually circled. Line 
thickness and color are proportional to the similarity coefficient between connected nodes. 
Node color is proportional to the FDR-adjusted P-value of the enrichment. Node size is 
proportional to gene set size.
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Figure 6. 
Augmented STAT5 signaling in Treg cells increases the conjugate formation between Treg 
cells and DCs and potentiates suppressor function in a TCR independent manner. (a) 
Analysis of in vitro conjugate formation between T cells and DCs. CFSE-labeled Treg and 
non-Treg cells from the indicated mice were co-cultured with graded numbers of CellTrace 
Violet-labeled CD11c+ DCs from C57BL/6J mice for 720 min in the absence (left panel) or 
presence (right panel) of rmIL-2 (100 IU/ml). Each dot represents a flow cytometric analysis 
of conjugate formation in a single well. (b) Expression of Foxp3 and TCR ? by CD4+ cells in 
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the LNs and spleen of Tcrafl/wt heterozygous mice treated with tamoxifen for 2 wks. The 
frequencies of TCR-sufficient and -deficient Foxp3+ cells among CD4+ cells are 
summarized in the right panel. (c) T cell activation and pro-inflammatory cytokine 
production in the LNs of indicated mice treated with tamoxifen for 2 wks. The lower five 
panels show the expression of the indicated molecules in LN Treg cells.
(d) The analysis of T cells transferred into Tcrb−/−Tcrd−/− recipients. WT CD4+Foxp3− and 
CD8+Foxp3− T cells (5 × 105 cells each) were transferred together with TCR-ablated 
(TCR ?loCD3lo) or TCR-sufficient Treg cells (3 × 105 cells) sorted from the indicated mice 
that had been treated with tamoxifen for 2 wks. The frequencies of Treg cells and Foxp3 
expression levels in Treg cells (upper two panels), the expression of the indicated molecules 
in Treg cells (middle three), and the numbers of cytokine producing CD4+ and CD8+ T cells 
(lower three) in the LNs of recipient mice 3 wks after the transfer are shown. Sex and age 
matched mice were analyzed. Cells were analyzed by flow cytometry (a–d). *, P < 0.05; **, 
P < 0.01; ***, P < 0.001 (modified ANCOVA in Prism software (a) or two-tailed unpaired 
Student's t test (b, c, d)). Data are from one experiment representative of three (a) or two (b, 
d) or four (c) independent experiments with similar results with three or more (b, c) or five 
or more (d) mice per group in each experiment (b, c, d; each dot represents a single mouse; 
mean ± s.e.m.).
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